Shivalik Rasayan Ltd
- Market Cap ₹ 1,138 Cr.
- Current Price ₹ 786
- High / Low ₹ 1,197 / 676
- Stock P/E 44.4
- Book Value ₹ 165
- Dividend Yield 0.06 %
- ROCE 15.7 %
- ROE 9.91 %
- Face Value ₹ 5.00
Pros
Cons
- Tax rate seems low
- Company has a low return on equity of 9.93% for last 3 years.
- Dividend payout has been low at 3.81% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 41 | 110 | 123 | 155 | 171 | 186 | 198 | 210 | |
| 38 | 99 | 105 | 131 | 147 | 157 | 159 | 163 | |
| Operating Profit | 3 | 10 | 18 | 24 | 24 | 29 | 38 | 47 |
| OPM % | 7% | 9% | 15% | 16% | 14% | 16% | 19% | 23% |
| 0 | 1 | 1 | 3 | 8 | 3 | 1 | 2 | |
| Interest | 0 | 5 | 6 | 4 | 3 | 2 | 2 | 2 |
| Depreciation | 0 | 2 | 2 | 2 | 3 | 4 | 9 | 10 |
| Profit before tax | 3 | 5 | 11 | 20 | 26 | 27 | 29 | 37 |
| Tax % | 33% | 33% | 25% | 25% | 20% | 17% | 15% | |
| Net Profit | 2 | 3 | 8 | 15 | 14 | 14 | 18 | 26 |
| EPS in Rs | 2.10 | 3.66 | 9.84 | 14.39 | 9.88 | 10.17 | 12.77 | 18.37 |
| Dividend Payout % | 0% | 0% | 4% | 3% | 5% | 2% | 4% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 8% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 41% |
| 3 Years: | 5% |
| TTM: | 70% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 41% |
| 3 Years: | 44% |
| 1 Year: | 7% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 10% |
| Last Year: | 10% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Sep 2021 | |
|---|---|---|---|---|---|---|---|---|
| 3 | 3 | 3 | 4 | 7 | 7 | 7 | 7 | |
| Reserves | 8 | 11 | 7 | 45 | 158 | 169 | 172 | 186 |
| Borrowings | 0 | 31 | 32 | 22 | 20 | 10 | 29 | 38 |
| 11 | 36 | 52 | 81 | 103 | 142 | 155 | 196 | |
| Total Liabilities | 23 | 81 | 94 | 152 | 288 | 328 | 363 | 427 |
| 7 | 27 | 27 | 40 | 41 | 52 | 210 | 218 | |
| CWIP | 0 | 0 | 0 | 0 | 26 | 102 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 16 | 53 | 66 | 111 | 222 | 175 | 153 | 209 | |
| Total Assets | 23 | 81 | 94 | 152 | 288 | 328 | 363 | 427 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
|---|---|---|---|---|---|---|---|
| 4 | 12 | 8 | -7 | -8 | 6 | 59 | |
| -0 | -18 | -4 | -24 | -24 | -102 | -79 | |
| 1 | 3 | -3 | 52 | 100 | 10 | 16 | |
| Net Cash Flow | 4 | -3 | 2 | 21 | 69 | -86 | -4 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 80 | 77 | 92 | 108 | 111 | 114 | 127 |
| Inventory Days | 5 | 64 | 76 | 65 | 71 | 65 | 34 |
| Days Payable | 126 | 152 | 137 | 103 | 123 | 171 | 152 |
| Cash Conversion Cycle | -41 | -11 | 31 | 71 | 59 | 7 | 9 |
| Working Capital Days | -9 | 48 | 70 | 110 | 150 | 160 | 98 |
| ROCE % | 33% | 39% | 43% | 22% | 15% | 16% |
Documents
Announcements
- Board to consider Final Dividend 18 May
- Board Meeting Intimation for Approval Of Audited Financial Results Of The Company (Standalone & Consolidated) For The Quarter / Year Ended On March 31, 2022. 18 May
-
Certificate Under Regulation 40(9) Of SEBI Listing Regulations 2015
14 Apr - Certificate under regulation 40(9) of SEBI Listing Regulations 2015 for the year ended on 31.03.2022 received from Practicing Company Secretary
-
Statement Of Investor Complaints For The Quarter Ended March 2022
12 Apr - No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter …
-
Compliance Certificate For The Year Ended On March 31, 2022
12 Apr - Compliance Certificate pursuant to Reg 7(3) of SEBI (LODR) Regulations, 2015 received from RTA
Business Segments
Shivalik Rasayan is into 2 business segments :
1. Agrochemicals: Largest producer of Dimethoate Technical and second largest producer of Malathion Technical in India.
2. API: The Company has commenced new pharma API manufacturing facility at PCPIR (Petroleum, Chemicals and Petrochemicals Investment Region) zone in Dahej (Gujarat) which is US FDA and EU standard compliant and provides one stop solution for direct commercial production, R&D, pilot scale batches, Contract Manufacturing (CMO) and Contract Research (CRO) services.[1]